Month: September 2023

News Alert

Ranking GOP Senator on Key Committee Opens Investigation into 340B Hospital Revenue

In Federal, News Alert, Providers, RegulatorySeptember 29, 2023759 Views

Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, sent letters to two health systems inquiring about their use of 340B savings.

The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Looming Government Shutdown Poses 340B Program Uncertainty, Potential Legal Proceeding Slowdown

In Federal, Judicial, RegulatorySeptember 28, 2023558 Views

William Newton

An increasingly likely government shutdown could impact 340B regulation and pending litigation surrounding the program.

The government agency that oversees the 340B program will retain just over half of its staff in the event of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

As Shutdown Looms, Momentum Slows on Bills with Key 340B Changes

In Legislative, ProvidersSeptember 28, 2023365 Views

William Newton

Rep. Harshbarger (R-Tenn.) co-sponsored a PBM transparency bill with a 340B provision, but there had not been any floor or committee votes scheduled on the legislation.

As the country moves closer to a federal government shutdown, movement on two bipartisan House bills with 340B program language, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

3 Ways to Maximize 340B Program Savings

In Sponsored ContentSeptember 28, 20231378 Views

Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice

In Pharma Industry, Providers, RegulatorySeptember 28, 2023209 Views

Tom Mirga

Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.

Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health, Researchers Spar over Biosimilar Study

In Providers, Research/Reports, Trade AssociationSeptember 28, 2023116 Views

Rich Daly

Maureen Testoni, president and CEO of 340B Health, traded letters to the editor of Health Affairs over a 340B study published in May.

Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Transparency, Patient Assistance Requirements Needed in 340B, Say Drugmaker-Backed Groups

In Legislative, Pharma Industry, Trade AssociationSeptember 28, 2023140 Views

Rich Daly

Justin Leventhal, a senior policy analyst for the American Consumer Institute, has advocated for more 340B transparency alongside other drugmaker-backed groups.

Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Column: Could the States Resolve the Contract Pharmacy Impasse?

In Judicial, Legislative, StateSeptember 28, 2023130 Views

Ted Slafsky

340B Report Publisher and CEO Ted Slafsky addresses enforcement actions and litigation surrounding state 340B contract pharmacy laws in his latest column.

After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to [...]